pulmonary-fibrosis

Documents about pulmonary-fibrosis

• Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect#860270ClinicalTrials.gov
• Safety, Tolerability and PK of Nintedanib in Combination With Pirfenidone in IPF#870562ClinicalTrials.gov
• Rehabilitation Counselling for Patients with Interstitial Lung Disease#917449ClinicalTrials.gov
• Oxygen Savings With Administered Oxygen and High Flow Ambient Air At Rest#261367ClinicalTrials.gov
• Effectiveness of Pulmonary Rehabilitation in Interstitial Lung Disease, Including Coronavirus Diseases: A Systematic Review and Meta-analysis#947565Repositorio de Universidad Autónoma de Chile.
• Burden of rare pathogenic variants suggests disrupted cytoskeletal organisation in the pathogenesis of pulmonary fibrosis#10117bioRxiv / medRxiv
• Vaccination of Ex-acute COVID-19 Patients With Fibrosing Lung Syndrome at Discharge#125912ClinicalTrials.gov
• A machine learning approach to identify perspectives of people living with pulmonary fibrosis.#636610NCBI PubMed Central
• Organelle Crosstalk and Metabolic Reprogramming in Idiopathic Pulmonary Fibrosis: Mechanisms and Therapeutic Implications.#659574NCBI PubMed Central
• Continuation of Nintedanib After Single Lung Transplantation in IPF Subjects#849465ClinicalTrials.gov
• A Trial of HRS-9813 Capsule and Tablet in Healthy Subjects#908226ClinicalTrials.gov
• Prospective Observation of Fibrosis in the Lung Clinical Endpoints Study#868568ClinicalTrials.gov
• A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy Volunteers#143790ClinicalTrials.gov
• Xenon-129 and Inert Fluorinated Gas Lung MRI: Study of Healthy Volunteers and Participants With Pulmonary Disease#980827ClinicalTrials.gov
• Progressive Muscle Relaxation in Pulmonary Rehab for Quality of Life, Mental Health, and Sleep in Cystic Fibrosis#895594ClinicalTrials.gov
• Decoding the ubiquitination-immunity axis in idiopathic pulmonary fibrosis: diagnostic insights and therapeutic implications.#25727NCBI PubMed Central
• An aerosolized dual-action autotaxin inhibitor-PPARγ agonist for the treatment of pulmonary fibrosis.#223005NCBI PubMed Central
• Data Management and Sharing Plan for: Metformin to Attenuate ProgressiVe RespIratory Decline in Idiopathic Pulmonary Fibrosis (MAVRIC-IPF)#297939UNC Dataverse Dataverse OAI Archive
• Workplace Productivity Loss in Patients with Progressive Pulmonary Fibrosis: Data from the ILD-PRO Registry.#334903NCBI PubMed Central
• Interstitial Lung Disease in Early Rheumatoid Arthritis#881184ClinicalTrials.gov
• Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF#893250ClinicalTrials.gov
• The role of glutamine metabolism in the pathogenesis of idiopathic pulmonary fibrosis and its therapeutic potential.#975701NCBI PubMed Central
• Neuropsychiatric disorders in pulmonary fibrosis: from brain network alterations to inflammatory mechanisms and therapeutic implications.#988341NCBI PubMed Central
• Pirfenidone to Prevent Fibrosis in Ards.#895541ClinicalTrials.gov
• A Comparison of a Medication Adherence Platform (FORTISKAP™) vs. Usual Care in Subjects on Oral Medications for the Treatment of Interstitial Lung Disease, Sarcoid and Pulmonary Hypertension#253116ClinicalTrials.gov
• Exercise Tolerance and Lower-limb Muscle Power in Patients With Chronic Respiratory Disease#838615ClinicalTrials.gov
• Modulatory roles of the vagus nerve and nicotine in bleomycin-induced pulmonary fibrosis in rats.#242384NCBI PubMed Central
• MRI staging of haemodynamic congestion and clinical outcomes#970732Europe PMC
• Development of a New Tool for Dyspnea Measurement in Chronic Respiratory Diseases#812299ClinicalTrials.gov
• Clinical Utility of the 1-minute Sit to Stand Test as a Measure of Submaximal Exercise Tolerance in Patients With Cystic Fibrosis During Acute Pulmonary Exacerbation#915072ClinicalTrials.gov
• Routine vs On-demand ECMO for Lung Transplantation#903196ClinicalTrials.gov
• A Study to Assess the Effect of AZD5055 on the Pharmacokinetics (PK) of Nintedanib in Healthy Participants.#857894ClinicalTrials.gov
• Exosomes as Disease-Informed Nanoplatforms for Pulmonary Fibrosis: From Pathogenic Signaling to Precision Diagnosis and Therapy.#319132NCBI PubMed Central
• Natural therapeutics and traditional formulas targeting macrophage polarization in the fibrotic niche of idiopathic pulmonary fibrosis.#371518NCBI PubMed Central
• S100A8(+)S100A9(+) transitional macrophages are associated with pulmonary fibrosis progression by integrating immunometabolism and fibrogenic crosstalk.#378515NCBI PubMed Central
• Pulmonary fibrosis after COVID-19 is characterized by airway abnormalities and elevated club cell secretory protein-16.#449948NCBI PubMed Central
• Familial pulmonary fibrosis: a UK consensus framework for the investigation and management of patients and their relatives#474730Apollo
• Multi-omics integration identifies APOE as a metabolic regulator of macrophage-fibroblast crosstalk in idiopathic pulmonary fibrosis.#636248NCBI PubMed Central
• The Role of Gastroesophageal Reflux in Scleroderma Pulmonary Fibrosis#857318ClinicalTrials.gov
• Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary Fibrosis#892126ClinicalTrials.gov
• Interstitial Lung Disease Exacerbations Study#913182ClinicalTrials.gov
• The Role of the Nervous System in Lung Disease#996397Europe PMC
• A Study of the Pharmacokinetic Interaction Between Pirfenidone and BMS-986278 in Healthy Participants#1032295ClinicalTrials.gov
• Exploring the Utility of Hyperpolarized 129Xe MRI in Healthy Volunteers and Patients With Lung Disease#838849ClinicalTrials.gov
• Aplicación del Índice de Desaturación-Distancia (DDR) en pacientes con Hipertensión Arterial Pulmonar (HAP): Seguimiento y Pronóstico de Supervivencia#641676Dipòsit Digital de la Universitat de Barcelona
• Network pharmacology and integrative bioinformatics analyses identify PDE1A as a key target of pirfenidone in idiopathic pulmonary fibrosis.#3764NCBI PubMed Central
• Polygenic risk scores enhance the identification of carriers of monogenic forms of idiopathic pulmonary fibrosis#192358bioRxiv / medRxiv
• Quantitative label-free multiphoton imaging of collagen features predicts disease severity and progression in idiopathic pulmonary fibrosis.#242244NCBI PubMed Central
• Anxiety and depression symptoms, coping strategies and appraisal of living with idiopathic pulmonary fibrosis: implications for psychological support#342192HAL (France)
• Single cell transcriptomics in a treatment-segregated cohort exposes a STAT3-regulated therapeutic gap in idiopathic pulmonary fibrosis#353169bioRxiv / medRxiv